These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28195089)

  • 1. Immunogenetics of chronic lymphocytic leukemia.
    Patkar N; Rabade N; Kadam PA; Mishra F; Muranjan A; Tembhare P; Chaudhary S; Joshi S; Jain H; Dangi U; Bagal B; Khattry N; Menon H; Gujral S; Sengar M; Subramanian PG
    Indian J Pathol Microbiol; 2017; 60(1):38-42. PubMed ID: 28195089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Overrepresentation of specific gene segments of expressed immunoglobulin heavy chain variable region among unmutated and mutated patients with chronic lymphocytic leukemia].
    Yu Z; Li ZJ; Yi SH; Zhou KS; Hao M; Qi JY; Li CH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):529-32. PubMed ID: 22338175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clonality analysis and mutation status of IgVH genes in classic Richter's syndrome].
    Mao ZR; Rosenwald A; Zhang SJ; Zhou R; Mueller-Hermelink HK
    Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):364-70. PubMed ID: 19031714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
    Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
    Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia.
    Chen L; Zhang Y; Zheng W; Wu Y; Qiao C; Fan L; Xu W; Li J
    Leuk Res; 2008 Oct; 32(10):1491-8. PubMed ID: 18359082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors].
    Xu W; Shen QD; Yu H; Qiao C; Wu YJ; Liu Q; Zhu DX; Miao KR; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):8-12. PubMed ID: 19563027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
    Schwarz J; Mikulenková D; Cermáková M; Polanská V; Michalová K; Marinov I; Campr V; Ransdorfová S; Marková J; Pavlistová L; Brezinová J; Sajdová J; Sponerová D; Volková Z; Benesová K; Cermák J; Vítek A; Cetkovský P
    Neoplasma; 2006; 53(3):219-25. PubMed ID: 16652191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [IgVH mutation status in patients with chronic lymphocytic leukemia].
    Zhang YP; Chen LJ; Zheng WJ; Wu YJ; Qiu HX; Qian SX; Xu W; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):164-7. PubMed ID: 18788614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a Northeastern region of Italy.
    Donisi PM; Di Lorenzo N; Riccardi M; Paparella A; Sarpellon C; Zupo S; Bertoldero G; Minotto C; Stracca-Pansa V
    Diagn Mol Pathol; 2006 Dec; 15(4):206-15. PubMed ID: 17122648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors.
    Oscier DG; Gardiner AC; Mould SJ; Glide S; Davis ZA; Ibbotson RE; Corcoran MM; Chapman RM; Thomas PW; Copplestone JA; Orchard JA; Hamblin TJ
    Blood; 2002 Aug; 100(4):1177-84. PubMed ID: 12149195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia.
    Sarsotti E; Marugan I; Benet I; Terol MJ; Sanchez-Izquierdo D; Tormo M; Rubio-Moscardo F; Martinez-Climent JA; García-Conde J
    Leukemia; 2004 Apr; 18(4):743-6. PubMed ID: 14961033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgVH gene mutation status and genomic imbalances in chronic lymphocytic leukaemia with increased prolymphocytes (CLL/PL).
    Balogh Z; Reiniger L; Deák L; Bödör C; Csomor J; Szepesi A; Gagyi E; Kopper L; Matolcsy A
    Hematol Oncol; 2007 Jun; 25(2):90-5. PubMed ID: 17410523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL).
    Del Giudice I; Davis Z; Matutes E; Osuji N; Parry-Jones N; Morilla A; Brito-Babapulle V; Oscier D; Catovsky D
    Leukemia; 2006 Jul; 20(7):1231-7. PubMed ID: 16642047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.
    Chen L; Li J; Zheng W; Zhang Y; Wu Y; Li L; Qian S; Xu W
    Leuk Lymphoma; 2007 Sep; 48(9):1785-92. PubMed ID: 17786715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of molecular and flow cytometric markers in chronic lymphocytic leukaemia.
    Sulda ML; Kuss BJ; Hall RK; Bailey S; Macardle PJ
    Intern Med J; 2012 Feb; 42(2):137-46. PubMed ID: 20561095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemia.
    Kern W; Dicker F; Schnittger S; Haferlach C; Haferlach T
    Cytometry B Clin Cytom; 2009 Nov; 76(6):385-93. PubMed ID: 19479984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia.
    Molica S; Digiesi G; Battaglia C; Cutrona G; Antenucci A; Molica M; Giannarelli D; Sperduti I; Gentile M; Morabito F; Ferrarini M
    Eur J Haematol; 2010 Oct; 85(4):314-20. PubMed ID: 20546021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors for chronic lymphocytic leukemia with typical and atypical immunophenotype].
    Cao X; Xu W; Wu YJ; Qiao C; Liu Q; Fan L; Miao KR; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jul; 30(7):450-3. PubMed ID: 19954596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
    Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.